APA

Li S., Liu T., Mo W., Hou Q., Zhou Y., Liu M., He Z., Liu Z., Chen Q., Wang H., Guo X., Xia W., Zeng M. & Zhao H. (20170403). Prognostic value of phosphorylated Raf kinase inhibitory protein at serine 153 and its predictive effect on the clinical response to radiotherapy in nasopharyngeal carcinoma. : Radiation oncology (London, England).

Chicago

Li Siwei, Liu Taowen, Mo Wenfa, Hou Qiaoyan, Zhou Yingqiong, Liu Meilian, He Zhoukai, Liu Zhengchun, Chen Qiuqiu, Wang Hua, Guo Xiang, Xia Weixiong, Zeng Musheng and Zhao Haiyun. 20170403. Prognostic value of phosphorylated Raf kinase inhibitory protein at serine 153 and its predictive effect on the clinical response to radiotherapy in nasopharyngeal carcinoma. : Radiation oncology (London, England).

Harvard

Li S., Liu T., Mo W., Hou Q., Zhou Y., Liu M., He Z., Liu Z., Chen Q., Wang H., Guo X., Xia W., Zeng M. and Zhao H. (20170403). Prognostic value of phosphorylated Raf kinase inhibitory protein at serine 153 and its predictive effect on the clinical response to radiotherapy in nasopharyngeal carcinoma. : Radiation oncology (London, England).

MLA

Li Siwei, Liu Taowen, Mo Wenfa, Hou Qiaoyan, Zhou Yingqiong, Liu Meilian, He Zhoukai, Liu Zhengchun, Chen Qiuqiu, Wang Hua, Guo Xiang, Xia Weixiong, Zeng Musheng and Zhao Haiyun. Prognostic value of phosphorylated Raf kinase inhibitory protein at serine 153 and its predictive effect on the clinical response to radiotherapy in nasopharyngeal carcinoma. : Radiation oncology (London, England). 20170403.